Minimal Residual Disease (MRD) Detection for Tumor Surgery
Product Highlights
  • CTCs reflect the nature of tumors more than ctDNA

  • Provide CTC quantitative results, which have greater clinical reference value

  • MRD testing can detect relapse 4-6 months earlier than imaging.

  • Extremely high negative predictive value avoids excessive adjuvant therapy

Labyrinth Workflow

Test Duration: 2-3 Days

  • Informed Consent Form

  •  

  • Collect 5-10 ml of Blood
    or Pleural Effusion, Ascites, Cerebrospinal Fluid

  •  

  • Enrichment and Purification

  •  

  • Pathological Analysis Report

Applicable People

Patients expecting to assess MRD after cancer surgery